2023
DOI: 10.3390/metabo13010077
|View full text |Cite
|
Sign up to set email alerts
|

The Role of Advanced Glycation End Products on Dyslipidemia

Abstract: Disorders of lipoprotein metabolism and glucose homeostasis are common consequences of insulin resistance and usually co-segregate in patients with metabolic syndrome and type 2 diabetes mellitus (DM). Insulin-resistant subjects are characterized by atherogenic dyslipidemia, a specific lipid pattern which includes hypertriglyceridemia, reduced high-density lipoprotein cholesterol level, and increased proportion of small, dense low-density lipoprotein (LDL). Chronic hyperglycemia favors the processes of non-enz… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 103 publications
0
4
0
Order By: Relevance
“…The consequence is inflammation and malfunction of many tissues and organs, including the liver, kidneys, blood vessels and nervous tissue. These disorders mutually reinforce each other and the accompanying pathologies accumulate with increasing age, which is associated with the progression of cardiometabolic factors such as insulin resistance, impaired glucose tolerance, hyperglycemia, hyperlipidemia, hypercholesterolemia, hypertension and central adiposity [ 1 , 2 , 3 , 4 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 ]. Belonging to the physiological α-ketoaldehydes, methylglyoxal is a highly reactive metabolite known for its harmful effects.…”
Section: Resultsmentioning
confidence: 99%
“…The consequence is inflammation and malfunction of many tissues and organs, including the liver, kidneys, blood vessels and nervous tissue. These disorders mutually reinforce each other and the accompanying pathologies accumulate with increasing age, which is associated with the progression of cardiometabolic factors such as insulin resistance, impaired glucose tolerance, hyperglycemia, hyperlipidemia, hypercholesterolemia, hypertension and central adiposity [ 1 , 2 , 3 , 4 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 ]. Belonging to the physiological α-ketoaldehydes, methylglyoxal is a highly reactive metabolite known for its harmful effects.…”
Section: Resultsmentioning
confidence: 99%
“…Up-raising IL-1β, NF-kβ signaling, insulin, and MGO contribute to renal dysfunction by insulin resistance and dyslipidemia induction [36,37]. FBS, insulin, HOMA, TG, TC, and LDL/HDL in the Pbi group were more than in other groups (Table 1).…”
Section: Discussionmentioning
confidence: 99%
“…Type II diabetes (T2D) is a chronic metabolic disease characterized by long-term hyperglycemia and insulin resistance (IR), and the decrease of insulin absorption and glucose utilization leads to more compensatory insulin secretion, resulting in hyperinsulinemia ( 57 , 58 ). Long-term hyperglycemia can lead to decreased organ function due to various health complications ( 59 , 60 ). A clinical observation showed that the height of the IVD decreased significantly in T2D patients, which may lead to an increase in the risk of vertebral fracture in T2D patients ( 61 ).…”
Section: Abnormal Glucose Metabolism and Iddmentioning
confidence: 99%